SANTA CLARA, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Applied Imaging
Corp. (Nasdaq: AICX) announced the release of the latest generation of its
CytoVision(R) genetic analysis system. This new release provides the
Company's clinical laboratory customers with faster processing speed,
additional functionality and improved productivity.
The new release of the CytoVision system addresses one of the major
challenges in cytogenetics laboratories -- maintaining efficiency,
productivity and throughput in the face of an increasing workload and a
decline in the number of qualified genetic technologists. Using CytoVision to
relieve this workload and increase case throughput, technologists can dedicate
their time to do the skilled analyses for which they are trained.
Applied Imaging is also introducing its concept of the paperless genetics
lab. By importing and integrating various documents along with the results of
the cytogenetic testing, CytoVision provides the laboratories with an
electronic database of information for seamless access by technologists, lab
directors and physicians.
This latest version of CytoVision also provides expanded functions to
assist in the detection of fluorescent-labeled DNA probes in cells. The
functions can be used in both clinical and research settings to aid the
cytogeneticist in the detection of specific genetic abnormalities, such as the
presence or absence of a particular segment of DNA. Genetic abnormalities are
often associated with the development of cancer and other diseases. Current
oncology research is focused on the development of therapies that can
precisely target specific genetic abnormalities. Patients who may benefit
from these therapies are identified by various biological and laboratory
factors, including fluorescent DNA probe results.
"We are very excited about these enhancements to our CytoVision system,"
commented Carl Hull, President and Chief Executive Officer of Applied Imaging.
"CytoVision has been the leading system for genetic imaging and analysis
purposes during the past decade, and our newest release reinforces our
commitment to meet the rapidly evolving needs of genetics analysis
laboratories throughout the world."
About Applied Imaging
Applied Imaging Corp., based in Santa Clara, California, is the leading
supplier of automated imaging systems utilized in genetics and pathology
laboratories throughout the world for the analysis of chromosomes in cancer
and prenatal disorders. The Company markets a range of imaging systems for
fluorescence and brightfield microscopy applications, including the Company's
Ariol(TM), MDS(TM), SPOT(TM), CytoVision(R), PowerGene(R) and QUIPS(R) product
lines. Applied Imaging has installed in excess of 3,000 systems in over 1,000
laboratories in more than 60 countries.
For additional information on Applied Imaging, visit the Company's Web
site at http://www.aicorp.com .
SOURCE Applied Imaging Corp.
 back to top
Related links:
http://www.aicorp.com
CONTACT:
Barry Hotchkies, CFO of Applied Imaging
Corp., +1-408-562-0250; or Jocelyn Hunter of FRB/Weber Shandwick,
+1-415-248-3433, for Applied Imaging Corp.
|
